Novo Nordisk has pledged to invest 60 billion kroner in Kalundborg, aiming to bolster local manufacturing and hire over 1,250 workers, yet locals report limited progress.
Despite the company’s success, Kalundborg faces an obesity crisis, with high rates of overweight children, raising issues of deprivation in a town overshadowed by its manufacturing plant.
"We will live there and then I can drive to Kalundborg to work," said regional councilor Helle Laursen Petersen, highlighting local concerns about teacher shortages and community services.
Novo Nordisk's market capitalization has reached about $500 billion, playing a pivotal role in the Danish economy's growth, yet it raises concerns about regional upheaval and equity.
Collection
[
|
...
]